Global Medical Foods Market Forecast to 2025 - Chronic Kidney Disorder is Expected to Emerge With the Fastest CAGR of 9.7% from 2019 to 2025

4/12/2019, 12:33 PM (Source: GlobeNewswire)

Dublin, April 12, 2019 (GLOBE NEWSWIRE) -- The "Medical Foods Market Size, Share & Trends Analysis By Route Of Administration (Oral, Enteral), By Product (Pills, Powders, Others), By Application, By Sales Channel (Retail, Online, Institutional), And Segment Forecasts, 2019 - 2025" report has been added to's offering.

The global medical foods market size is expected to reach USD 27.2 billion by 2025, registering a CAGR of 6.7% from 2019 to 2025, according to this report.

Rising geriatric population and increasing prevalence of chronic diseases are among the key factors driving the market. According to the WHO estimates published in February 2018, the population aged 60 years and above is expected to increase from 12% in 2015 to 22% by 2050.

Non-communicable diseases impose a high economic burden on health systems globally. According to a study conducted by the researchers from University of Lige, Belgium, the population suffering from sarcopenia in Europe is expected to increase from 11.1% in 2016 to 12.9% in 2045.

Medical foods help treat and prevent age-related sarcopenia. Thus, the demand for medical foods in the management of chronic conditions, such as sarcopenia, is expected to augment the market development. Moreover, various public and private initiatives in the field of clinical nutrition is projected to boost the market further.

A number of manufacturers are extending their capabilities in the sports nutrition market with various strategic initiatives, such as M&A and new product launches, to fulfill the escalating demand. For instance, in May 2016, Hormel Foods introduced HORMEL VITAL CUISINE, a range of Ready-to-Eat (RTE) meals, whey protein powders, and nutritional shakes. This product line was specially designed to meet the nutritional requirements of cancer patients.

Further key findings from the study suggest:

  • Orally administered medical foods accounted for the highest revenue share and are projected to maintain the dominance in future owing to ease in administration and their commercial viability
  • Enteral administration is expected to witness the fastest CAGR of 7.2% over the forecast period
  • Diabetic neuropathy held the largest revenue share in 2018 owing to high disease prevalence. However, chronic kidney disorder is expected to emerge with the fastest CAGR of 9.7% from 2019 to 2025
  • Institutional sales emerged as the largest sales channel segment in 2018. However, the online sales segment is projected to register the fastest CAGR during the forecast years
  • Asia Pacific is among the prominent regions owing to huge geriatric population base and high burden of chronic diseases
  • Danone S.A., Nestle S.A., Abbott Laboratories, Fresenius Kabi, and Mead Johnsons & Company, LLC are the major companies in the medical foods market

Companies Mentioned

  • Danone
  • Nestle
  • Abbott
  • Targeted Medical Pharma Inc.
  • Primus Pharmaceuticals Inc.
  • Mead Johnson & Company LLC
  • Fresenius Kabi AG

Key Topics Covered

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Information Procurement
1.4 Primary Research
1.5 Information Analysis
1.6 Market Formulation & Data Visualization
1.7 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Medical Foods Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Pricing Analysis
3.4 User Prespective Analysis
3.5 Technology Outlook
3.6 Regulatory Framework
3.7 Market Dynamics
3.8 Medical Foods Market Analysis Tools

Chapter 4 Medical Foods Market-Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Competition Categorization
4.3 Vendor Landscape
4.4 Public Companies
4.5 Private Companies

Chapter 5 Medical Foods Market: Route of Administration Estimates & Trend Analysis
5.1 Definition and scope
5.2 Route of Administration Market Share Analysis, 2018 & 2025
5.3 Segment Dashboard
5.4 Market Revenue Estimates and Forecasts, by Route of Administration, 2014 - 2025 (USD Million)

Chapter 6 Medical Foods Market: Products Estimates & Trend Analysis
6.1 Definition and scope
6.2 Product Market Share Analysis, 2018 & 2025
6.3 Segment Dashboard
6.4 Global Medical Foods Market Revenue Estimates and Forecasts, by Products, 2014 - 2025 (USD Million)

Chapter 7 Medical Foods Market: Application Estimates & Trend Analysis
7.1 Market Definition and Scope
7.2 Application Market Share Analysis, 2018 & 2025
7.3 Segment Dashboard
7.4 Market Revenue Estimates and Forecasts, by Applications, 2014 - 2025 (USD Million)

Chapter 8 Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1 Market Definition and Scope
8.2 Sales Channel Market Share Analysis, 2018 & 2025
8.3 Segment Dashboard
8.4 Market Revenue Estimates and Forecasts, by Sales Channel, 2014-2025

Chapter 9 Medical Foods Market: Regional Estimates & Trend Analysis, by Route of Administration, Product, Application, and Sales Channel
9.1 Medical Foods Market: Regional Market Snapshot, 2018 & 2025, USD Million (Market Size, CAGR, Top Verticals, Top Trends)
9.2 Regional Market Share and Leading Players, 2018
9.3 North America
9.4. Europe
9.5. Asia Pacific
9.6 Latin America
9.7. Middle East & Africa (MEA)
9.8 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)

Chapter 10 Company Profiles
10.1 Company Profiles
10.2 List of Other Market Players

For more information about this report visit

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals


Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.